These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10508714)

  • 1. Bispecific antibodies in cancer therapy.
    Segal DM; Weiner GJ; Weiner LM
    Curr Opin Immunol; 1999 Oct; 11(5):558-62. PubMed ID: 10508714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant bispecific antibodies for cellular cancer immunotherapy.
    Müller D; Kontermann RE
    Curr Opin Mol Ther; 2007 Aug; 9(4):319-26. PubMed ID: 17694444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant bispecific antibodies for cancer therapy.
    Kontermann RE
    Acta Pharmacol Sin; 2005 Jan; 26(1):1-9. PubMed ID: 15659107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bispecific antibodies for cancer therapy.
    Hollander N
    Immunotherapy; 2009 Mar; 1(2):211-22. PubMed ID: 20635943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the generation of bispecific antibodies for tumor immunotherapy.
    Kipriyanov SM; Le Gall F
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):233-42. PubMed ID: 15603258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bispecific antibodies targeting cancer cells.
    Peipp M; Valerius T
    Biochem Soc Trans; 2002 Aug; 30(4):507-11. PubMed ID: 12196124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy.
    van Ojik HH; Valerius T
    Crit Rev Oncol Hematol; 2001 Apr; 38(1):47-61. PubMed ID: 11255081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting T cells with bispecific antibodies for cancer therapy.
    Lum LG; Thakur A
    BioDrugs; 2011 Dec; 25(6):365-79. PubMed ID: 22050339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promise of bispecific antibodies: Clinical applications and challenges.
    Lim SM; Pyo KH; Soo RA; Cho BC
    Cancer Treat Rev; 2021 Sep; 99():102240. PubMed ID: 34119803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bispecific antibodies for cancer immunotherapy: Current perspectives.
    Müller D; Kontermann RE
    BioDrugs; 2010 Apr; 24(2):89-98. PubMed ID: 20199124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future.
    Fournier P; Schirrmacher V
    BioDrugs; 2013 Feb; 27(1):35-53. PubMed ID: 23329400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bispecific antibodies for cancer therapy.
    Chames P; Baty D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bispecific T-cell engaging antibodies for cancer therapy.
    Baeuerle PA; Reinhardt C
    Cancer Res; 2009 Jun; 69(12):4941-4. PubMed ID: 19509221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bispecific antibodies in hematology and oncology].
    Repp R; Valerius T; Bargou R
    Internist (Berl); 2001 Jun; 42(6):854-9. PubMed ID: 11449632
    [No Abstract]   [Full Text] [Related]  

  • 15. Bispecific antibodies in cancer therapy, from the laboratory to the clinic.
    Koelemij R; Kuppen PJ; van de Velde CJ; Fleuren GJ; Hagenaars M; Eggermont AM
    J Immunother; 1999 Nov; 22(6):514-24. PubMed ID: 10570750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors.
    Satta A; Mezzanzanica D; Turatti F; Canevari S; Figini M
    Future Oncol; 2013 Apr; 9(4):527-39. PubMed ID: 23560375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of cancer vaccines by virus infection and attachment of bispecific antibodies. An effective alternative to somatic gene therapy.
    Schirrmacher V; Haas C
    Adv Exp Med Biol; 1998; 451():251-7. PubMed ID: 10026882
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of bispecific antibodies in the therapy of tumors.
    Fanger MW; Morganelli PM; Guyre PM
    Cancer Treat Res; 1993; 68():181-94. PubMed ID: 8105851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative molecular formats and therapeutic applications for bispecific antibodies.
    Spiess C; Zhai Q; Carter PJ
    Mol Immunol; 2015 Oct; 67(2 Pt A):95-106. PubMed ID: 25637431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction history of bispecific antibodies and overview of its application for cancer immunotherapy].
    Asano R
    Seikagaku; 2005 Dec; 77(12):1497-501. PubMed ID: 16440753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.